Dr. Elizabeth Rebello

Dr. Elizabeth Rebello is a representative from the University of Texas MD Anderson Cancer Center, who voiced concerns during the FDA advisory committee meetings about the lack of scientific evidence supporting the safety and efficacy of the proposed peptides for compounding.